TWC
CRDL

TD Waterhouse Canada’s Cardiol Therapeutics CRDL Stock Holding History

TD Waterhouse Canada’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25K Hold
6,900
– – ﹤0.01% 1903
2026
Q1 		$9.49K Sell
6,900
-300
-4% -$308 ﹤0.01% 1768
2025
Q4 		$6.87K Buy
7,200
+300
+4% +$314 ﹤0.01% 1630
2025
Q3 		$7.44K Hold
6,900
– – ﹤0.01% 1607
2025
Q2 		$8.96K Hold
6,900
– – ﹤0.01% 1478
2025
Q1 		$6.43K Hold
6,900
– – ﹤0.01% 1488
2024
Q4 		$8.77K Hold
6,900
– – ﹤0.01% 1440
2024
Q3 		$13.7K Hold
6,900
– – ﹤0.01% 1300
2024
Q2 		$13.7K Hold
6,900
– – ﹤0.01% 1300
2024
Q1 		$16.6K Hold
6,900
– – ﹤0.01% 1261
2023
Q4 		$8.21K Hold
6,900
– – ﹤0.01% 1292
2023
Q3 		$8K Hold
6,900
– – ﹤0.01% 1280
2023
Q2 		$8K Hold
6,900
– – ﹤0.01% 1294
2023
Q1 		$4.62K Hold
6,900
– – ﹤0.01% 1386
2022
Q4 		$4.97K Hold
6,900
– – ﹤0.01% 1351
2022
Q3 		$9.45K Hold
6,900
– – ﹤0.01% 1242
2022
Q2 		$11.8K Hold
6,900
– – ﹤0.01% 1216
2022
Q1 		$12.5K Hold
6,900
– – ﹤0.01% 1270
2021
Q4 		$15.8K Buy
+6,900
New +$19.1K ﹤0.01% 1249

Other funds holding CRDL

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
BFS
Boyer Financial Services Newport Beach, California $118M AUM
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

TD Waterhouse Canada's CRDL Position: Q2 2026 in Review

TD Waterhouse Canada held its Cardiol Therapeutics (CRDL) position steady in Q2 2026 at 6,900 shares worth $7.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

TD Waterhouse Canada first reported a position in CRDL in Q4 2021 and has held it in 19 quarters since. The position peaked at $16.6K in Q1 2024. 8 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • TD Waterhouse Canada held 6,900 shares of Cardiol Therapeutics worth $7.25K as of Q2 2026.
  • TD Waterhouse Canada left its Cardiol Therapeutics share count unchanged in Q2 2026.
  • Cardiol Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1903 holding.
  • TD Waterhouse Canada first reported a position in Cardiol Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Cardiol Therapeutics position peaked at $16.6K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.